ALDH1A2
Retinal dehydrogenase 2
Also known as: AL1A2_HUMAN, RALDH2
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O94788
- Gene
- ALDH1A2
- Ensembl
- ENSG00000128918
- Chromosome
- 15
- Canonical length
- 518 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted intracellular proteins
- Quaternary structure
- Homotetramer
OverviewNCBI Gene
This protein belongs to the aldehyde dehydrogenase family of proteins. The product of this gene is an enzyme that catalyzes the synthesis of retinoic acid (RA) from retinaldehyde. Retinoic acid, the active derivative of vitamin A (retinol), is a hormonal signaling molecule that functions in developing and adult tissues. The studies of a similar mouse gene suggest that this enzyme and the cytochrome CYP26A1, concurrently establish local embryonic retinoic acid levels which facilitate posterior organ development and prevent spina bifida. Four transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, May 2011]
Canonical amino-acid sequenceUniProt
518 residues, UniProt reviewed canonical sequence.
>O94788|ALDH1A2
1 MTSSKIEMPG EVKADPAALM ASLHLLPSPT PNLEIKYTKI FINNEWQNSE SGRVFPVYNP
61 ATGEQVCEVQ EADKADIDKA VQAARLAFSL GSVWRRMDAS ERGRLLDKLA DLVERDRAVL
121 ATMESLNGGK PFLQAFYVDL QGVIKTFRYY AGWADKIHGM TIPVDGDYFT FTRHEPIGVC
181 GQIIPWNFPL LMFAWKIAPA LCCGNTVVIK PAEQTPLSAL YMGALIKEAG FPPGVINILP
241 GYGPTAGAAI ASHIGIDKIA FTGSTEVGKL IQEAAGRSNL KRVTLELGGK SPNIIFADAD
301 LDYAVEQAHQ GVFFNQGQCC TAGSRIFVEE SIYEEFVRRS VERAKRRVVG SPFDPTTEQG
361 PQIDKKQYNK ILELIQSGVA EGAKLECGGK GLGRKGFFIE PTVFSNVTDD MRIAKEEIFG
421 PVQEILRFKT MDEVIERANN SDFGLVAAVF TNDINKALTV SSAMQAGTVW INCYNALNAQ
481 SPFGGFKMSG NGREMGEFGL REYSEVKTVT VKIPQKNSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ALDH1A2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.22
- Highest tissue expression
- 77 nTPM
Expression across tissuesHPA
Tissue
- endometrium: 77 nTPM
- fallopian tube: 70 nTPM
- testis: 54 nTPM
- seminal vesicle: 50 nTPM
- cervix: 49 nTPM
- smooth muscle: 30 nTPM
Single-cell type
- neutrophils: 1,959 nCPM
- epicardial cells: 1,001 nCPM
- pituitary stem cells: 842 nCPM
- endometrial stromal cells: 494 nCPM
- hepatocytes: 403 nCPM
- decidual stromal cells: 394 nCPM
Immune cell
- neutrophil: 33 nTPM
- basophil: 2.1 nTPM
- classical monocyte: 0.5 nTPM
- non-classical monocyte: 0.3 nTPM
- intermediate monocyte: 0.2 nTPM
- eosinophil: 0 nTPM
Brain region
- cerebral cortex: 27 nTPM
- hippocampal formation: 17 nTPM
- choroid plexus: 7 nTPM
- thalamus: 5.1 nTPM
- cerebellum: 4.2 nTPM
- basal ganglia: 3.9 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ALDH1A2.
Disease | AllUniProt
Conditions ALDH1A2 is implicated in, by any mechanism.
- Diaphragmatic hernia 4, with cardiovascular defects (DIH4) MIM:620025
Disease | GeneticClinVar
4 pathogenic / likely-pathogenic of 90 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Diaphragmatic hernia 4, with cardiovascular defects
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.45
- gnomAD pLI
- 0.36
- gnomAD missense Z
- 1.44
- DepMap mean gene effect
- -0.04
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- 9-cis-retinoic acid biosynthetic process
- aldehyde metabolic process
- blood vessel development
- cardiac muscle tissue development
- cell population proliferation
- cellular response to retinoic acid
- embryonic camera-type eye development
- embryonic digestive tract development
- embryonic forelimb morphogenesis
- face development
- heart morphogenesis
- hindbrain development
- kidney development
- liver development
- lung development
- midgut development
- morphogenesis of embryonic epithelium
- negative regulation of cell population proliferation
- neural crest cell development
- neural tube development
- neuron differentiation
- pancreas development
- pituitary gland development
- positive regulation of apoptotic process
- positive regulation of cell population proliferation
- positive regulation of gene expression
- protein homotetramerization
- proximal/distal pattern formation
- regulation of vascular endothelial cell proliferation
- response to cytokine
- response to estradiol
- response to retinoic acid
- response to vitamin A
- retinal metabolic process
- retinoic acid biosynthetic process
- retinoic acid metabolic process
- retinoic acid receptor signaling pathway
- retinol metabolic process
- somitogenesis
- ureter maturation
- vitamin A metabolic process
- determination of bilateral symmetry
Molecular functions
- 3-chloroallyl aldehyde dehydrogenase activity
- aldehyde dehydrogenase (NAD+) activity
- retinal binding
- retinal dehydrogenase (NAD+) activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ALDH1A2 as an antibody target. Whether an autoantibody or antibody against ALDH1A2 could matter depends on whether native ALDH1A2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ALDH1A2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ALDH1A2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...